395 completed, 38 terminated, 23 unknown, 17 withdrawn. 499 Phase 1, 73 Phase 2.
Follow Respiratory Hypersensitivity: new trials by email Literature Review of Respiratory Hypersensitivity trials Research Report on Respiratory Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anakinra Rescue Treatment for Moderate Asthma Attacks (ARTMA) Anakinra 100 Mg/0.67 Ml Inj Syringe, Saline Placebo/0.67 Ml Inj Syringe - Asthma (Diagnosis), Persistent Asthma | Phase 1 | Not yet recruiting | University of North Carolina, Chapel Hill | 60 | 2026-11-01 | 2026-07-15 |
| Evaluation of Safety, Side Effects, and How the Drug, Inhaled CHF10136, Is Absorbed, Modified and Removed From the Body in Healthy Adults and Adults With Asthma CHF10136, CHF10136 matched placebo - Asthma, Healthy Volunteers | Phase 1 | Recruiting | Chiesi Farmaceutici S.p.A. | 120 | 2026-10-02 | 2026-10-13 |
| A Randomized, Double-Blind, Placebo-Controlled Phase Ib Study of Multiple Ascending Doses of EB070 Injection in Adults With Moderate-to-Severe Asthma EB070 - Asthma | Phase 1 | Not yet recruiting | Biotech Pharmaceutical Co., Ltd. | 20 | 2026-09-30 | 2026-10-21 |
| Efficacy and Safety of Yiqi Wenyang Sanhan Formula Combined With Acupoint Application in Patients With Combined Allergic Rhinitis and Asthma Syndrome During Remission and Yang-Deficiency Syndrome Yiqi Wenyang Sanhan Formula Combined with Acupoint Application, placebo of Yiqi Wenyang Sanhan Formula combined with acupoint application - Allergic Rhinitis With Asthma | Phase 1 | Not yet recruiting | Beijing Daxing District Hospital of Integrated Chinese and Western Medicine | 188 | 2026-09-01 | 2026-04-20 |
| A Randomized, Phase Ib, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SKB575 (HBM7575) in Participants With Asthma SKB575, Placebo - Asthma (Diagnosis) | Phase 1 | Recruiting | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 36 | 2026-08-25 | 2026-09-10 |
| A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers AMG 691 - Healthy Participants | Phase 1 | Recruiting | Amgen | 28 | 2026-08-07 | 2026-08-27 |
| A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283 GSK5784283 - Asthma | Phase 1 | Recruiting | GlaxoSmithKline | 24 | 2026-07-17 | 2026-07-29 |
| Phase 1, First in Human (FIH), Open-Label, Single-Arm, Ascending Dose Study to Assess the Safety, Tolerability and Preliminary Immunogenicity of ITI-9001 in Japanese Patients With Japanese Red Cedar (JRC) Pollinosis ITI-9001, Placebo - Allergen Immunotherapy | Phase 1 | Recruiting | Immunomic Therapeutics, Inc. | 45 | 2026-06-20 | 2026-09-25 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma PF-08103402, Placebo, Midazolam - Healthy Volunteer Study, Healthy Adults | Phase 1 | Recruiting | Pfizer | 133 | 2026-06-17 | 2026-10-13 |
| A Study of CDX-622 in Participants With Mild to Moderate Asthma CDX-622 - Mild to Moderate Asthma | Phase 1 | Recruiting | Celldex Therapeutics | 12 | 2026-06-01 | 2026-07-02 |
| A Phase 1 Study of Cizutamig in IgE Mediated Diseases Cizutamig - IgE-Mediated Hypersensitivity, IgE Mediated Food Allergy | Phase 1 | Withdrawn | Candid Therapeutics | 2026-04-01 | 2026-07-22 | |
| A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma Budesonide/formoterol fumarate Aerosphere, Budesonide/formoterol fumarate pMDI - Asthma | Phase 1 | Completed | AstraZeneca | 16 | 2026-03-05 | 2026-07-15 |
| ADO-5030 in Bronchoconstriction Challenge, Phase 1b ADO-5030 - Asthma (Diagnosis) | Phase 1 | Not yet recruiting | Adovate | 36 | 2026-01-01 | 2026-01-22 |
| Bioequivalence Study of AJU-R713 and R713R in Healthy Adult Volunteers AJU-R713, R713R - Bronchial Asthma, Perennial Allergic Rhinitis | Phase 1 | Completed | AJU Pharm Co., Ltd. | 62 | 2025-12-12 | 2026-09-18 |
| Phase I Study of PollenVax in Patients With Mugwort Pollen-Induced Allergic Rhinitis PollenVax, Placebo - Rhinitis Allergic | Phase 1 | Completed | Kazakh National Agrarian University | 30 | 2025-11-22 | 2026-06-29 |
| Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma PRA-216, Placebo - Mild to Moderate Asthma | Phase 1 / Phase 2 | Recruiting | Prana Therapies Inc | 96 | 2025-11-04 | 2026-08-06 |
| A Clinical Study to Evaluate SM17 in Healthy Participants SM17, SM17 placebo - Atopic Dermatitis, Asthma | Phase 1 | Completed | SinoMab BioScience Ltd | 30 | 2025-10-14 | 2026-04-06 |
| Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma ALUTARD SQ® Felis domesticus - Allergic Rhinitis, Allergic Asthma | Phase 1 / Phase 2 | Recruiting | University of Zurich | 36 | 2025-08-20 | 2026-03-16 |
| The Safety, Feasibility, and Repeatability of Inhaled ATP Cough Challenges Adenosine 5'-triphosphate - Chronic Cough (CC), Asthma | Phase 1 | Recruiting | McMaster University | 33 | 2025-08-05 | 2025-08-29 |
| A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Asthma Placebo, IBI3002 - Asthma | Phase 1 | Recruiting | The First Affiliated Hospital of Soochow University | 12 | 2025-06-20 | 2025-11-19 |
Showing 20 of 499. Sign in to see all of them.
Asthma (397) · Rhinitis, Allergic (79) · Pulmonary Disease, Chronic Obstructive (45) · Rhinitis, Allergic, Seasonal (35) · Hypersensitivity (34) · Rhinitis, Allergic, Perennial (15) · Dermatitis, Atopic (10) · Inflammation (8) · Rhinitis (7) · Cystic Fibrosis (5) · Dust Mite Allergy (5) · Lung Diseases (5) · Respiratory Tract Diseases (5) · Urticaria (5) · Conjunctivitis, Allergic (4)
Hypersensitivity, Immediate (497) · Immune System Diseases (495) · Respiratory Tract Diseases (494) · Hypersensitivity (465) · Bronchial Diseases (399) · Lung Diseases, Obstructive (397) · Lung Diseases (395) · Nose Diseases (118) · Otorhinolaryngologic Diseases (118) · Rhinitis (111) · Pathological Conditions, Signs and Symptoms (74) · Pathologic Processes (61) · Disease Attributes (47) · Chronic Disease (46)
Budesonide (25) · Fluticasone (22) · montelukast (12) · Charcoal (10) · Formoterol Fumarate (10) · Albuterol (8) · Saline Solution (8) · Salmeterol Xinafoate (8) · Sodium Chloride (8) · Antigens, Dermatophagoides (6) · Budesonide, Formoterol Fumarate Drug Combination (6) · Fluticasone-Salmeterol Drug Combination (6) · Prednisone (6) · fluticasone furoate (6) · Allergens (5)
GlaxoSmithKline (69) · AstraZeneca (39) · Orion Corporation, Orion Pharma (13) · University of North Carolina, Chapel Hill (13) · Merck Sharp & Dohme LLC (12) · Chiesi Farmaceutici S.p.A. (10) · MedImmune LLC (9) · Pfizer (9) · Amgen (7) · Boehringer Ingelheim (7) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · Intech Biopharm Ltd. (6) · Novartis Pharmaceuticals (6) · Teva Branded Pharmaceutical Products R&D, Inc. (6) · Novartis (5)
United States (153) · United Kingdom (90) · Germany (51) · Australia (35) · China (35) · Canada (21) · South Korea (12) · Finland (11) · New Zealand (11) · Belgium (10) · Netherlands (8) · Taiwan (7) · Sweden (6) · Denmark (5) · Greece (5)
Michelle Hernandez, MD (5) · Robert Wood, MD (5) · Cecil Charles, PhD (3) · Chrysoula Doxani, MD, MSc, PhD (3) · Dave Singh (3) · David B Peden, MD, MS (3)
PMID 24184147, PMID 19001265, PMID 22464647, PMID 19680119, PMID 22726593, PMID 23374268, PMID 24035151, PMID 26706294, PMID 29550052, PMID 32907575, PMID 36184023, PMID 40185989, PMID 10831441, PMID 11069570, PMID 11163535, PMID 11297958, PMID 11468003, PMID 11728816, PMID 15379842, PMID 15764724, PMID 16164444, PMID 16553814, PMID 17083353, PMID 17717202, PMID 18244953, PMID 19446146, PMID 19647862, PMID 19717725, PMID 19821718, PMID 19944580, PMID 20921983, PMID 20976161, PMID 21057005, PMID 21639872, PMID 21642470, PMID 21725898, PMID 21729182, PMID 22393898, PMID 22544892, PMID 22616628, PMID 22621776, PMID 22955319, PMID 22989372, PMID 23102735, PMID 23176889, PMID 23181790, PMID 23706713, PMID 23725004, PMID 24093504, PMID 24105252
2016 (8), 2014 (6), 2015 (6), 2019 (4), 2009 (3), 2018 (3), 2023 (3), R01HL135235 (3), 2017 (2), P01AT002620 (2), P01AT002647 (2), P01HL158507 (2), U19AI095261 (2), 2008 (1), KL2TR002346 (1)